In Teruyuki’s study, the bone marrow-derived cells were obtained from 15 patients with pediatric precursor B-ALL that were sorted into different subsets by FACS, and CD19+ cells were treated as normal B cells for the analysis. Here, CD19 is linked to acute lymphoblastic leukemia.